Drugs / UCLSCs
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04811261 | Nov 2021 → Jul 2023 | angiodysplasia | University of Florida | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | UCLSCs | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04811261 ↗ |
| Known as | Umbilical cord lining stem cells | “This is a Phase I, single ascending dose, first in human, open-label, non-controlled, dose-escalation trial that will investigate intravenous infusions of Umbilical cord lining...” NCT04811261 ↗ |
| Route | Intravenous | “This Phase Ia single-ascending dose pilot study will evaluate the IV administration of ULSCs in stable out-patients supported with an LVAD.” PMID 38559284 ↗ May 2022 |